Xtant Financial Statements From 2010 to 2025

XTNT Stock  USD 0.48  0.03  5.88%   
Xtant Medical financial statements provide useful quarterly and yearly information to potential Xtant Medical Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Xtant Medical financial statements helps investors assess Xtant Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Xtant Medical's valuation are summarized below:
Gross Profit
68.2 M
Profit Margin
(0.14)
Market Capitalization
66.6 M
Enterprise Value Revenue
0.8149
Revenue
117.3 M
There are currently one hundred twenty fundamental gauges for Xtant Medical Holdings that can be evaluated and compared over time across peers. All traders should confirm Xtant Medical's prevalent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Enterprise Value is likely to gain to about 104.6 M in 2025, whereas Market Cap is likely to drop slightly above 37.7 M in 2025.

Xtant Medical Total Revenue

123.13 Million

Check Xtant Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Xtant Medical's main balance sheet or income statement drivers, such as Interest Expense of 5.3 M, Total Revenue of 123.1 M or Gross Profit of 36.4 M, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.0 or PTB Ratio of 1.31. Xtant financial statements analysis is a perfect complement when working with Xtant Medical Valuation or Volatility modules.
  
Check out the analysis of Xtant Medical Correlation against competitors.

Xtant Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets62.5 M93.8 M62.7 M
Slightly volatile
Other Current Liabilities3.6 MM3.1 M
Slightly volatile
Total Current Liabilities16.9 M28.6 M16.1 M
Slightly volatile
Accounts Payable5.1 M7.9 MM
Pretty Stable
Cash5.8 M6.2 MM
Slightly volatile
Cash And Short Term Investments5.8 M6.2 MM
Slightly volatile
Net Receivables10.5 M20.7 M10.5 M
Slightly volatile
Common Stock Shares Outstanding140.3 M133.7 M40 M
Slightly volatile
Liabilities And Stockholders Equity62.5 M93.8 M62.7 M
Slightly volatile
Inventory40.6 M38.6 M20 M
Slightly volatile
Other Stockholder Equity317.9 M302.7 M161.2 M
Slightly volatile
Total Liabilities60.5 M50.9 M60.8 M
Very volatile
Total Current Assets35.9 M67.1 M35.9 M
Slightly volatile
Short and Long Term Debt Total12.3 M12.9 M44.1 M
Very volatile
Property Plant And Equipment Net8.1 M11 M7.7 M
Slightly volatile
Current Deferred Revenue6.5 M7.6 M6.3 M
Slightly volatile
Non Current Assets Total28.2 M26.7 M27.1 M
Very volatile
Non Currrent Assets Other97.8 K103 K1.3 M
Slightly volatile
Common Stock Total Equity1.711.812.1569
Slightly volatile
Non Current Liabilities Total21.2 M22.3 M43.3 M
Very volatile
Property Plant And Equipment Gross32.3 M30.8 M11.5 M
Slightly volatile
Short Term Debt14.3 M13.7 MM
Slightly volatile
Intangible Assets7.8 M8.4 M7.6 M
Very volatile
Common Stock1.711.847.0944
Slightly volatile
Other Assets0.860.91.2 M
Slightly volatile
Long Term Debt20.9 M22 M42.3 M
Very volatile
Property Plant Equipment7.6 M6.7 M6.9 M
Pretty Stable
Other Liabilities5.3 M5.7 M6.4 M
Slightly volatile
Short and Long Term Debt11.5 M12.1 M21.8 M
Very volatile
Long Term Debt Total8.3 M8.7 M70.8 M
Slightly volatile
Capital Surpluse177 M319.5 M161.8 M
Slightly volatile
Capital Lease Obligations1.5 M985 K1.3 M
Slightly volatile
Net Invested Capital58.1 M77.1 M64.7 M
Slightly volatile
Net Working Capital29.2 M38.5 M21.1 M
Slightly volatile

Xtant Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue123.1 M117.3 M62.4 M
Slightly volatile
Gross Profit36.4 M68.2 M36.3 M
Slightly volatile
Other Operating Expenses65.2 M129.3 M64.9 M
Slightly volatile
Cost Of Revenue51.5 M49.1 M23.9 M
Slightly volatile
Total Operating Expenses43.5 M80.3 M42.9 M
Slightly volatile
Depreciation And Amortization3.1 M3.7 MM
Pretty Stable
Selling General Administrative15.4 M28.7 M14.3 M
Slightly volatile
Selling And Marketing Expenses29.3 M49.2 M26.8 M
Slightly volatile
Non Recurring61.7 M58.8 M28.8 M
Slightly volatile
Reconciled DepreciationM4.2 M5.7 M
Slightly volatile

Xtant Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow5.5 M5.9 M5.6 M
Slightly volatile
End Period Cash Flow5.9 M6.2 MM
Slightly volatile
Stock Based Compensation4.3 M4.1 M1.7 M
Slightly volatile
Depreciation3.2 M4.2 M3.1 M
Pretty Stable
Cash Flows Other Operating425.8 K448.2 K5.2 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.480.504914.6981
Slightly volatile
Days Sales Outstanding73.2764.305464.3392
Very volatile
Average Payables9.4 M8.9 M7.5 M
Slightly volatile
Stock Based Compensation To Revenue0.03710.03510.0339
Slightly volatile
Capex To Depreciation0.910.97370.8154
Very volatile
EV To Sales0.530.562415.2517
Slightly volatile
Inventory Turnover2.111.26962.1039
Slightly volatile
Days Of Inventory On Hand378287303
Pretty Stable
Payables Turnover3.946.19495.2801
Slightly volatile
Sales General And Administrative To Revenue0.320.24470.2875
Slightly volatile
Average Inventory11.6 M17.8 M17.5 M
Slightly volatile
Research And Ddevelopement To Revenue0.02620.02030.0227
Pretty Stable
Capex To Revenue0.03310.03510.0288
Very volatile
Cash Per Share0.04410.04642.7359
Slightly volatile
Days Payables Outstanding11258.919786.5167
Slightly volatile
Intangibles To Total Assets0.130.16690.1683
Very volatile
Current Ratio1.742.34832.2933
Slightly volatile
Receivables Turnover4.685.6765.9846
Very volatile
Capex Per Share0.02920.03081.2476
Slightly volatile
Average Receivables4.5 M8.9 M7.9 M
Slightly volatile
Revenue Per Share0.830.877333.7574
Slightly volatile
Interest Debt Per Share0.120.127936.5046
Slightly volatile
Debt To Assets0.130.13790.6609
Pretty Stable
Graham Number0.180.210.2273
Slightly volatile
Operating Cycle452352367
Pretty Stable
Days Of Payables Outstanding11258.919786.5167
Slightly volatile
Ebt Per Ebit1.581.34691.9346
Pretty Stable
Long Term Debt To Capitalization0.0010.00110.8574
Slightly volatile
Total Debt To Capitalization0.220.23150.9373
Slightly volatile
Quick Ratio0.860.99651.1638
Pretty Stable
Cash Ratio0.330.21690.4561
Pretty Stable
Cash Conversion Cycle339293281
Slightly volatile
Days Of Inventory Outstanding378287303
Pretty Stable
Days Of Sales Outstanding73.2764.305464.3392
Very volatile
Fixed Asset Turnover5.9410.69957.5128
Slightly volatile
Debt Ratio0.130.13790.6609
Pretty Stable
Price Sales Ratio0.480.504914.6981
Slightly volatile
Asset Turnover1.31.24971.2264
Slightly volatile
Gross Profit Margin0.490.58170.5893
Pretty Stable

Xtant Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap37.7 M59.2 M47.8 M
Very volatile
Enterprise Value104.6 M66 M90.6 M
Very volatile

Xtant Fundamental Market Drivers

Cash And Short Term Investments6.2 M

Xtant Upcoming Events

5th of March 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Xtant Medical Financial Statements

Xtant Medical shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Xtant Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Xtant Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Xtant Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue7.6 M6.5 M
Total Revenue117.3 M123.1 M
Cost Of Revenue49.1 M51.5 M
Stock Based Compensation To Revenue 0.04  0.04 
Sales General And Administrative To Revenue 0.24  0.32 
Research And Ddevelopement To Revenue 0.02  0.03 
Capex To Revenue 0.04  0.03 
Revenue Per Share 0.88  0.83 
Ebit Per Revenue(0.10)(0.11)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Xtant Stock Analysis

When running Xtant Medical's price analysis, check to measure Xtant Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xtant Medical is operating at the current time. Most of Xtant Medical's value examination focuses on studying past and present price action to predict the probability of Xtant Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xtant Medical's price. Additionally, you may evaluate how the addition of Xtant Medical to your portfolios can decrease your overall portfolio volatility.